Post-Transplant Peptides: Protect the Graft Before You Add Anything

About this video

In this short clinical Q&A clip, Seeds responds to a question about peptide protocols for a post-transplant patient by insisting that graft protection and monitoring come before adding anything. He lists what he says must be characterized first: kidney filtration and urine protein, blood levels of the patient’s immunosuppressant drugs, immunoglobulin levels, autoimmune markers, and whether a routine biopsy has been done, particularly where autoimmune liver disease is a concern. He notes the rationale for one immunosuppressant includes kidney protection and guarding against recurrence of the autoimmune problem. Crucially, he points out that two signaling nodes clinicians might otherwise target are deliberately suppressed by the transplant regimen itself, which constrains what can safely be layered on top.

Key takeaways

• In transplant patients, characterize and monitor the graft before considering any add-on therapy
• Immunosuppressant drug levels and autoimmune markers are part of the baseline picture Seeds wants
• Existing immunosuppression deliberately blocks pathways that other therapies might aim to stimulate
• A full supplement and medication inventory matters before judging what is safe to add

Episode details: published September 21, 2026 · 91 views · 2:58 long. Summary written by Self Growth Videos from the episode itself. The peptide and cellular-medicine concepts described are Dr. William Seeds’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: the SSRP Institute sells clinician certification in peptide therapy.

← Previous: Do Peptides Cause Cancer? · Next: Ep.78 - Do Peptides Cause Cancer? The Risks, The Myths, And The Evidence →

All Dr. William Seeds videos · Dr. William Seeds profile · SSRP Institute (official site)